GlassScriptPhysician profile
Katherine Lai
NPI 1639263577
$4,602.84
in general payments reported to CMS, 2019-2025
29 companies · $861 in 2025
The $861 reported for 2025 was more than what 83% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $450 · 2021: $599 · 2022: $607 · 2023: $531 · 2024: $877 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,932 · Travel and Lodging: $220 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.09 |
| Travel and Lodging | $219.70 |
| Education | $116.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $665.18 | 2019-2025 | Prostep Mica, Ortholoc 3di, Gravity |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $607.89 | 2019-2025 | Jublia |
| Organogenesis INC. | $323.85 | 2020-2025 | Via Matrix, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $315.16 | 2022-2025 | |
| Bioventus LLC | $302.70 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $273.08 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $250.92 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $210.39 | 2021-2023 | |
| Horizon Therapeutics Plc | $195.63 | 2020-2021 | |
| Amgen INC. | $173.53 | 2024-2025 | Krystexxa |
| Abbott Laboratories | $164.55 | 2019 | |
| Melinta Therapeutics, LLC | $151.59 | 2019-2021 | |
| Smith+Nephew, INC. | $140.37 | 2020-2021 | |
| Medtronic, INC. | $133.58 | 2024 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $131.90 | 2022-2023 | Seglentis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $110.97 | 2021-2025 | Nuzyra |
| Sebela Pharmaceuticals INC. | $80.99 | 2021-2023 | Naftin, Pramosone |
| Sandoz INC. | $78.94 | 2019-2020 | |
| Nevro Corp. | $65.65 | 2021-2022 | |
| Lifenet Health | $42.32 | 2025 | Theragenesis Wound Matrix |
| Zimmer Biomet Holdings, INC. | $36.30 | 2021 | |
| Resmed Corp | $26.11 | 2023 | |
| Globus Medical, INC. | $25.19 | 2025 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $18.34 | 2019 | |
| Heron Therapeutics, INC. | $16.39 | 2021 | |
| Forte Bio-Pharma LLC | $15.73 | 2022 | |
| Convatec INC. | $15.64 | 2021 | |
| Orthofix Medical, INC. | $15.55 | 2022 | |
| Dynasplint Systems INC. | $14.40 | 2024 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.